Use of selenium in chemoprevention of bladder cancer

Lancet Oncology

Volumn 7, Issue 9, 2006, Pages 766-774

  Brinkman, Maree ^a   Buntinx, Frank ^a,d   Muls, Erik ^b   Zeegers, Maurice P ^a,c  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^c UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^d MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; BIOLOGICAL MARKER; PLACEBO; SELENATE; SELENIUM; SELENOCYSTEINE; SELENOMETHIONINE; SODIUM SELENITE;

ALCOHOLIC BEVERAGE; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; BLADDER CANCER; BLADDER CARCINOMA; BREAST CANCER; CANCER CELL CULTURE; CANCER INHIBITION; CANCER MORTALITY; CANCER RECURRENCE; CANCER RESEARCH; CASE CONTROL STUDY; CHEMOPROPHYLAXIS; CLINICAL TRIAL; COFFEE; DOSE RESPONSE; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG EXCRETION; DRUG MECHANISM; DRUG METABOLISM; DRUG SAFETY; EPIDEMIOLOGICAL DATA; FEMALE; FOOD COMPOSITION; FOOD DRUG INTERACTION; GASTROINTESTINAL DISEASE; GEOGRAPHY; HAIR DISEASE; HUMAN; IN VITRO STUDY; MALE; MEDICAL ASSESSMENT; MELANOMA; NAIL DISEASE; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; RABBIT; RAT; REVIEW; SEX DIFFERENCE; TEA; TREATMENT OUTCOME; VITAMIN SUPPLEMENTATION;

ANTIOXIDANTS; CHEMOPREVENTION; HUMANS; SELENIUM; URINARY BLADDER NEOPLASMS;

EID: 33747832457     PISSN: 14702045     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1470-2045(06)70862-2     Document Type: Review

References (75)

1. Parkin D., Bray F., Ferlay J., and Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 55 (2005) 74-108
2. Kirkali Z., Chan T., Manoharan M., et al. Bladder cancer: epidemiology, staging and grading, and diagnosis. Urology 66 (2005) 4-34
3. Schulz W. Understanding urothelial carcinoma through cancer pathways. Int J Cancer 119 (2006) 1513-1518
4. Wu X. Urothelial tumorigenesis: a tale of divergent pathways. Nat Rev Cancer 5 (2005) 713-725
5. Zeegers M., Tan F., Dorant E., and van Den Brandt P. The impact of characteristics of cigarette smoking on urinary tract cancer risk: a meta-analysis of epidemiologic studies. Cancer 89 (2000) 630-639
6. Zeegers M., Kellen E., Buntinx F., and van den Brandt P. The association between smoking, beverage consumption, diet and bladder cancer: a systematic literature review. World J Urol 21 (2004) 392-401
7. Perera F. Environment and cancer: who are susceptible?. Science 278 (1997) 1068-1073
8. Negri E., and La Vecchia C. Epidemiology and prevention of bladder cancer. Eur J Cancer Prev 10 (2001) 7-14
9. Zeegers M., Goldbohm A., Bode P., and van den Brandt P. Prediagnostic toenail selenium and risk of bladder cancer. Cancer Epidemiol Biomarkers Prev 11 (2002) 1292-1297
10. Kamat A., and Lamm D. Chemoprevention of urological cancer. J Urol 161 (1999) 1748-1760
11. Shamberger R., Tytko S., and Willis C. Antioxidants and cancer. Part VI. Selenium and age-adjusted human cancer mortality. Arch Environ Health 31 (1976) 231-235
12. Schrauzer G., White D., and Schneider C. Cancer mortality correlation studies-III: statistical associations with dietary selenium intakes. Bioinorg Chem 7 (1977) 23-31
13. Clark L., Cantor K., and Allaway W. Selenium in forage crops and cancer mortality in US counties. Arch Environ Health 46 (1991) 37-42
14. Klein E., and Thompson I. Update on chemoprevention of prostate cancer. Curr Opin Urol 14 (2004) 143-149
15. Whanger P. Selenium and its relationship to cancer: an update dagger. Br J Nutr 91 (2004) 11-28
16. Lipinski B. Rationale for the treatment of cancer with sodium selenite. Med Hypotheses 64 (2005) 806-810
17. Vinceti M., Rovesti S., Bergomi M., and Vivoli G. The epidemiology of selenium and human cancer. Tumori 86 (2000) 105-118
18. Rayman M. The use of high-selenium yeast to raise selenium status: how does it measure up?. Br J Nutr 92 (2004) 557-573
19. Tinggi U. Essentiality and toxicity of selenium and its status in Australia: a review. Toxicol Lett 137 (2003) 103-110
20. Brenneisen P., Steinbrenner H., and Sies H. Selenium, oxidative stress, and health aspects. Mol Aspects Med 26 (2005) 256-267
21. Platz E., and Helzlsouer K. Selenium, zinc, and prostate cancer. Epidemiol Rev 23 (2001) 93-101
22. Schrauzer G., and White D. Selenium in human nutrition: dietary intakes and effects of supplementation. Bioinorg Chem 8 (1978) 303-318
23. Young V., Nahapetian A., and Janghorbani M. Selenium bioavailability with reference to human nutrition. Am J Clin Nutr 35 (1982) 1076-1088
24. Janghorbani M., Xia Y., Ha P., et al. Metabolism of selenite in men with widely varying selenium status. J Am Coll Nutr 18 (1999) 462-469
25. Robinson J., Robinson M., Levander O., and Thompson C. Urinary excretion of selenium by New Zealand and North American human subjects on differing intakes. Am J Clin Nutr 41 (1985) 1023-1031
26. Swanson C., Longnecker M., Veillon C., et al. Selenium intake, age, gender, and smoking in relation to indices of selenium status of adults residing in a seleniferous area. Am J Clin Nutr 52 (1990) 858-862
27. Kuehnelt D., Kienzl N., Traar P., et al. Selenium metabolites in human urine after ingestion of selenite, L-selenomethionine, or DL-selenomethionine: a quantitative case study by HPLC/ICPMS. Anal Bioanal Chem 383 (2005) 235-246
28. 74Se]selenomethionine metabolism: a kinetic model. Am J Clin Nutr 54 (1991) 917-926
29. Hawkes W., Alkan F., and Oehler L. Absorption, distribution and excretion of selenium from beef and rice in healthy North American men. J Nutr 133 (2003) 3434-3442
30. Levander O., and Morris V. Dietary selenium levels needed to maintain balance in North American adults consuming self-selected diets. Am J Clin Nutr 39 (1984) 809-815
31. Waters D., Chiang E., Cooley D., and Morris J. Making sense of sex and supplements: differences in the anticarcinogenic effects of selenium in men and women. Mutat Res 551 (2004) 91-107
32. Rodriguez Rodriguez E., Sanz Alaejos M., and Diaz R. Urinary selenium status of healthy people. Eur J Clin Chem Clin Biochem 33 (1995) 127-133
33. Garland M., Morris J., Rosner B., et al. Toenail trace element levels as biomarkers: reproducibility over a 6-year period. Cancer Epidemiol Biomarkers Prev 2 (1993) 493-497
34. Longnecker M., Stram D., Taylor P., et al. Use of selenium concentration in whole blood, serum, toenails, or urine as a surrogate measure of selenium intake. Epidemiology 7 (1996) 384-390
35. Slotnick M., and Nriagu J. Validity of human nails as a biomarker of arsenic and selenium exposure: a review. Environ Res 102 (2006) 125-139
36. Gauchez A., Riondel J., Jacrot M., et al. Antioxidant status and lipid peroxidation in athymic mice xenografted with two types of human tumors. Biol Trace Elem Res 47 (1995) 103-109
37. Combs Jr. G., and Gray W. Chemopreventive agents: selenium. Pharmacol Ther 79 (1998) 179-192
38. El Bayoumy K. The protective role of selenium on genetic damage and on cancer. Mutat Res 475 (2001) 123-139
39. El Bayoumy K., and Sinha R. Molecular chemoprevention by selenium: a genomic approach. Mutat Res 591 (2005) 224-236
40. Borawska M., Witkowska A., Hukalowicz K., and Markiewicz R. Influence of dietary habits on serum selenium concentration. Ann Nutr Metab 48 (2004) 134-140
41. Redman C., Scott J., Baines A., et al. Inhibitory effect of selenomethionine on the growth of three selected human tumor cell lines. Cancer Lett 125 (1998) 103-110
42. Ip C., and Dong Y. Methylselenocysteine modulates proliferation and apoptosis biomarkers in premalignant lesions of the rat mammary gland. Anticancer Res 21 (2001) 863-867
43. Menter D., Sabichi A., and Lippman S. Selenium effects on prostate cell growth. Cancer Epidemiol Biomarkers Prev 9 (2000) 1171-1182
44. El Bayoumy K., and Sinha R. Mechanisms of mammary cancer chemoprevention by organoselenium compounds. Mutat Res 551 (2004) 181-197
45. Mohandas J., Marshall J., Duggin G., et al. Low activities of glutathione-related enzymes as factors in the genesis of urinary bladder cancer. Cancer Res 44 (1984) 5086-5091
46. Lijinsky W., Milner J., Kovatch R., and Thomas B. Lack of effect of selenium on induction of tumors of esophagus and bladder in rats by two nitrosamines. Toxicol Ind Health 5 (1989) 63-72
47. Nomura A., Heilbrun L., Morris J., and Stemmermann G. Serum selenium and the risk of cancer, by specific sites: case-control analysis of prospective data. J Natl Cancer Inst 79 (1987) 103-108
48. Helzlsouer K., Comstock G., and Morris J. Selenium, lycopene, alpha-tocopherol, beta-carotene, retinol, and subsequent bladder cancer. Cancer Res 49 (1989) 6144-6148
49. Knekt P., Aromaa A., Maatela J., et al. Serum micronutrients and risk of cancers of low incidence in Finland. Am J Epidemiol 134 (1991) 356-361
50. Garland M., Morris J., Stampfer M., et al. Prospective study of toenail selenium levels and cancer among women. J Natl Cancer Inst 87 (1995) 497-505
51. Michaud D., Hartman T., Taylor P., et al. No association between toenail selenium levels and bladder cancer risk. Cancer Epidemiol Biomarkers Prev 11 (2002) 1505-1506
52. Michaud D., De Vivo I., Morris J., and Giovannucci E. Toenail selenium concentrations and bladder cancer risk in women and men. Br J Cancer 93 (2005) 804-806
53. Torun M., Aldemir H., and Yardim S. Serum selenium levels in various cancer types. Trace Elem Electrolytes 12 (1995) 186-190
54. Yalcin O., Karatas F., Erulas F., and Ozdemir E. The levels of glutathione peroxidase, vitamin A, E, C and lipid peroxidation in patients with transitional cell carcinoma of the bladder. BJU Int 93 (2004) 863-866
55. Kellen E, Zeegers M, Buntinx F. Selenium is inversely associated with cancer risk: the Belgian case control study on bladder cancer. Int J Urol 2006 (in press).
56. Bratakos M., Vouterakos T., and Ioannou P. Selenium status of cancer patients in Greece. Sci Total Environ 92 (1990) 207-222
57. Salonen J., Alfthan G., Huttunen J., and Puska P. Association between serum selenium and the risk of cancer. Am J Epidemiol 120 (1984) 342-349
58. Ringstad J., Jacobsen B., Tretli S., and Thomassen Y. Serum selenium concentration associated with risk of cancer. J Clin Pathol 41 (1988) 454-457
59. Brooks J., Metter E., Chan D., et al. Plasma selenium level before diagnosis and the risk of prostate cancer development. J Urol 166 (2001) 2034-2038
60. Gupta S., Narang R., Krishnaswami K., and Yadav S. Plasma selenium level in cancer patients. Indian J Cancer 31 (1994) 192-197
61. Kornitzer M., Valente F., De Bacquer D., et al. Serum selenium and cancer mortality: a nested case-control study within an age- and sex-stratified sample of the Belgian adult population. Eur J Clin Nutr 58 (2004) 98-104
62. Salonen J., Salonen R., Lappetelainen R., et al. Risk of cancer in relation to serum concentrations of selenium and vitamins A and E: matched case-control analysis of prospective data. Br Med J (Clin Res Ed) 290 (1985) 417-420
63. Kok F., De Bruijn A., Hofman A., et al. Is serum selenium a risk factor for cancer in men only?. Am J Epidemiol 125 (1987) 12-16
64. Ujiie S., and Kikuchi H. The relation between serum selenium value and cancer in Miyagi, Japan: 5-year follow up study. Tohoku J Exp Med 196 (2002) 99-109
65. Clark L., Combs Jr. G., Turnbull B., et al. Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group. JAMA 276 (1996) 1957-1963
66. Grossman H. Chemoprevention of bladder cancer. Urology 67 (2006) 19-22
67. Gee J., Sabichi A., and Grossman H. Chemoprevention of superficial bladder cancer. Crit Rev Oncol Hematol 43 (2002) 277-286
68. Sylvester R., van der Meijden A., Oosterlinck W., et al. Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials. Eur Urol 49 (2006) 466-565
69. Reid M., Stratton M., Lillico A., et al. A report of high-dose selenium supplementation: response and toxicities. J Trace Elem Med Biol 18 (2004) 69-74
70. Clark L., and Marshall J. Randomized, controlled chemoprevention trials in populations at very high risk for prostate cancer: elevated prostate-specific antigen and high-grade prostatic intraepithelial neoplasia. Urology 57 (2001) 185-187
71. Bosetti C., and La Vecchia C. Cancer mortality in Latin America: implications for prevention. Rev Panam Salud Publica 18 (2005) 1-4
72. Longnecker M., Taylor P., Levander O., et al. Selenium in diet, blood and toenails in relation to human health in a high seleniferous area. Am J Clin Nutr 53 (1991) 1288-1294
73. Michaud D., Spiegelman D., Clinton S., et al. Prospective study of dietary supplements, macronutrients, micronutrients, and risk of bladder cancer in US men. Am J Epidemiol 152 (2000) 1145-1153
74. Jacobs E., Henion A., Briggs P., et al. Vitamin C and vitamin E supplement use and bladder cancer mortality in a large cohort of US men and women. Am J Epidemiol 156 (2002) 1002-1010
75. Zeegers M., Goldbohm R., and van den Brandt P. Are retinol, vitamin C, vitamin E, folate and carotenoids intake associated with bladder cancer risk? Results from the Netherlands Cohort Study. Br J Cancer 85 (2001) 977-983